The RPE-IgG conjugation kit utilizes a novel chemistry to generate highly reproducible IgG-RPE conjugates with a simple procedure. It allows users to generate their own liquid stable conjugates that are highly stable at working concentrations, can be customized and are fully scalable from 0.01 mg to gram scale. The resulting conjugates have been shown to be extremely stable, retaining nearly 100% activity after storage for 2 months at 37ºC. Each kit includes all reagents needed to conjugate the stated amount of IgG at a 1:1 RPE:IgG ratio. Manufacturing quality systems ensure excellent sensitivity, low background, and lot to-lot consistency. Kits are available for conjugation of 0.3mg, 1mg and 5mg. No license needed for commercial use.
The Native Antigen Company (TNAC) manufactures and supplies antigens, antibodies and conjugation kits. TNAC was acquired in July 2020 by The LGC Group, and is now part of the LGC Clinical Diagnostics business unit.